Ambeed.cn

首页 / / / / Deferoxamine/去铁胺

Deferoxamine/去铁胺 {[allProObj[0].p_purity_real_show]}

货号:A698741 同义名: Deferoxamine B; Deferrioxamine

Deferoxamine is a medication that binds iron and aluminium. It has been previously reported to induce hypoxia and hypoxia-inducible factor-1α (HIF-1α) expression.

Deferoxamine/去铁胺 化学结构 CAS号:70-51-9
Deferoxamine/去铁胺 化学结构
CAS号:70-51-9
Deferoxamine/去铁胺 3D分子结构
CAS号:70-51-9
Deferoxamine/去铁胺 化学结构 CAS号:70-51-9
Deferoxamine/去铁胺 3D分子结构 CAS号:70-51-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Deferoxamine/去铁胺 纯度/质量文件 产品仅供科研

货号:A698741 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

更多 >
产品名称 Akt Akt1 Akt2 Akt3 其他靶点 纯度
Honokiol MEK 98%
PF-04691502 ++++

P-Akt (T308), IC50: 7.5 nM

P-Akt (S473), IC50: 3.8 nM

98+%
PHT-427 +

Akt, Ki: 2.7 μM

99%+
Deguelin PI3K 99%+
TIC10 isomer ERK 98+%
Perifosine +

Akt, IC50: 4.7 μM

98%
Miltefosine PKC,PI3K 98%
Triciribine +

Akt, IC50: 130 nM

99%+
Uprosertib +

Akt1, IC50: 180 nM

+

Akt2, IC50: 328 nM

++

Akt3, IC50: 38 nM

99%+
Afuresertib ++++

Akt1, Ki: 0.08 nM

++++

Akt2, Ki: 2 nM

++++

Akt3, Ki: 2.6 nM

99%+
Miransertib ++++

Akt1, IC50: 5 nM

++++

Akt2, IC50: 4.5 nM

++

Akt3, IC50: 16 nM

98+%
GSK-690693 ++++

Akt1, IC50: 2 nM

+++

Akt2, IC50: 13 nM

+++

Akt3, IC50: 9 nM

99%+
AT7867 ++

Akt1, IC50: 32 nM

++

Akt2, IC50: 17 nM

++

Akt3, IC50: 47 nM

PKA 99%+
AKT inhibitor VIII ++

Akt1, IC50: 58 nM

+

Akt2, IC50: 210 nM

+

Akt3, IC50: 2119 nM

97%
MK-2206 2HCl +++

Akt1, IC50: 8 nM

+++

Akt2, IC50: 12 nM

+

Akt3, IC50: 65 nM

99%+
Ipatasertib ++++

Akt1, IC50: 5 nM

++

Akt2, IC50: 18 nM

+++

Akt3, IC50: 8 nM

99%+
AT13148 ++

Akt1, IC50: 38 nM

+

Akt2, IC50: 402 nM

++

Akt3, IC50: 50 nM

PKA 95%
Capivasertib ++++

Akt1, IC50: 3 nM

+++

Akt2, IC50: 8 nM

+++

Akt3, IC50: 8 nM

99%+
A-674563 HCl +++

Akt1, Ki: 11 nM

PKA 99%
CCT128930 +++

Akt2, IC50: 6 nM

PKA 95%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。
产品名称 Autophagy 其他靶点 纯度
SBI-0206965 +++

ULK2, IC50: 711 nM

ULK1, IC50: 108 nM

95%
Hydroxychloroquine sulfate 99%
Valproic acid sodium HDAC 97%
PFK-015 ++

PFKFB3, IC50: 207 nM

99%+
MRT68921 HCl ++++

ULK2, IC50: 1.1 nM

ULK1, IC50: 2.9 nM

99%+
ROC-325 99%+
Autophinib +++

Autophagy, IC50: 40 nM

99%
Lys05 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。
产品名称 HIF HIF1 PHD1 PHD2 PHD3 其他靶点 纯度
KC7F2 +

HIF-1α, IC50: 20 μM

+

HIF-1α, IC50: 20 μM

98%
Lificiguat 99%+
BAY 87-2243 99%+
PX-478·2HCl 98%+
2-Methoxyestradiol 98%
CAY10585 ++

HIF, IC50: 4.4 μM

BCRP 97%
DMOG 98%
FG 2216 ++

PHD2, IC50: 3.9 μM

99%+
MK-8617 ++++

PHD1, IC50: 1 nM

++++

PHD2, IC50: 1 nM

++++

PHD3, IC50: 14 nM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Deferoxamine/去铁胺 生物活性

描述 Deferoxamine is a medication that binds iron and aluminium. It has been previously reported to induce hypoxia and hypoxia-inducible factor-1α (HIF-1α) expression.

Deferoxamine/去铁胺 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00502788 Hepatitis C T... 展开 >>halassemia 收起 << Phase 2 Completed - United States, California ... 展开 >> Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609 United States, New York Weill Medical College of Cornell University New York, New York, United States, 10021 United States, Pennsylvania Children's Hospital Philadelphia Philadelphia, Pennsylvania, United States, 19104 Canada, Ontario Toronto General Hospital, Universty Health Network Toronto, Ontario, Canada, M5G 2C4 United Kingdom University College London London, United Kingdom, WC1E 6HX 收起 <<
NCT00447694 Beta-thalassemia ... 展开 >> Iron Overload 收起 << Phase 2 Completed - United States, California ... 展开 >> Childrens Hospital of Los Angeles Los Angeles, California, United States, 90027 Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 收起 <<
NCT01441375 - Completed - United States, Louisiana ... 展开 >> Tulane University New Orleans, Louisiana, United States, 70112 United States, Tennessee Universit of Tennessee Memphis, Tennessee, United States, 38163 收起 <<

Deferoxamine/去铁胺 参考文献

[1]Mu S, Guo S, et al. Effects of deferoxamine on the osteogenic differentiation of human periodontal ligament cells. Mol Med Rep. 2017 Dec;16(6):9579-9586.

[2]Yu J, Yuan Q, et al. Effects of Deferoxamine Mesylate on Hematoma and Perihematoma Edema after Traumatic Intracerebral Hemorrhage. J Neurotrauma. 2017 Oct 1;34(19):2753-2759.

Deferoxamine/去铁胺 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.78mL

0.36mL

0.18mL

8.92mL

1.78mL

0.89mL

17.84mL

3.57mL

1.78mL

Deferoxamine/去铁胺 技术信息

CAS号70-51-9
分子式C25H48N6O8
分子量 560.68
SMILES Code O=C(N(CCCCCN)O)CCC(NCCCCCN(C(CCC(NCCCCCN(C(C)=O)O)=O)=O)O)=O
MDL No. MFCD00242585
别名 Deferoxamine B; Deferrioxamine; Deferriferrioxamine B
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。